Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Solid Malignant Tumors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00033241
What this trial is testing

Erlotinib Combined With Gemcitabine in Treating Patients With Newly Diagnosed Locally Advanced or Metastatic Pancreatic Cancer or Other Solid Tumors

Who this might be right for
Pancreatic CancerUnspecified Adult Solid Tumor, Protocol Specific
OSI Pharmaceuticals
Early research (Phase 1)Ended earlyNCT06130254
What this trial is testing

Phase Ib Trial of the KRAS G12C Inhibitor Adagrasib (MRTX849) in Combination With the PARP Inhibitor Olaparib in Patients With KRAS G12C Mutated Advanced Solid Tumors, With a Focus on Gynecological, Breast, Pancreatic and KEAP1 Mutated Non-small Cell Lung Cancers

Who this might be right for
Advanced Solid TumorNon-small Cell Lung Cancers
M.D. Anderson Cancer Center 1
Early research (Phase 1)Looking for participantsNCT06541639
What this trial is testing

EVM16 Injection as a Single and Combination With Tislelizumab in Solid Tumors

Who this might be right for
Advanced or Recurrent Solid Tumors
Peking University 78
Early research (Phase 1)Active Not RecruitingNCT03889795
What this trial is testing

Phase IB Metformin, Digoxin, Simvastatin in Solid Tumors

Who this might be right for
Advanced Pancreatic CancerAdvanced Solid Tumor
Danae Hamouda, MD 15
Early research (Phase 1)Study completedNCT02916095
What this trial is testing

Kanitinib in Treating Patients With Advanced Solid Tumors

Who this might be right for
Solid Tumors
Beijing Konruns Pharmaceutical Co., Ltd. 9
Testing effectiveness (Phase 2)Ended earlyNCT00910039
What this trial is testing

Sunitinib Malate After Stereotactic Radiosurgery in Treating Patients With Newly Diagnosed Brain Metastases

Who this might be right for
Cognitive/Functional EffectsMetastatic CancerUnspecified Adult Solid Tumor, Protocol Specific
Case Comprehensive Cancer Center 14
Early research (Phase 1)Study completedNCT02182206
What this trial is testing

An Dose Escalation Study of Treatment With BIBF 1120 in Patients With Advanced Solid Tumours

Who this might be right for
Tumors
Boehringer Ingelheim 50
Early research (Phase 1)Study completedNCT02025803
What this trial is testing

A Safety, Tolerability and Pharmacokinetic Study of TAS-114 in Combination With Capecitabine in Patients With Advanced Solid Tumors

Who this might be right for
Neoplasms
Taiho Oncology, Inc. 60
Early research (Phase 1)Looking for participantsNCT05005403
What this trial is testing

Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan

Who this might be right for
Non-Small Cell Lung CancerHead and Neck Squamous Cell CarcinomaMicro Satellite Stable Colorectal Cancer+4 more
AbbVie
Not applicableWithdrawnNCT01936961
What this trial is testing

Study of Immunochemotherapy +/- Hypofractionated Radiation for Complete Response in Solid Tumors

Who this might be right for
Metastatic Non-Small Cell Lung CancerMetastatic Colon CancerMetastatic Triple Negative Breast Cancer
Western Regional Medical Center
Early research (Phase 1)Study completedNCT00483366
What this trial is testing

Imatinib Mesylate, Gemcitabine, and Capecitabine in Treating Patients With Advanced Solid Tumors

Who this might be right for
Unspecified Adult Solid Tumor, Protocol Specific
University of Nebraska 13
Early research (Phase 1)Study completedNCT00603356
What this trial is testing

Phase I Study of OSI-930 and Erlotinib in Cancer Tumors

Who this might be right for
Advanced Solid Tumors
Astellas Pharma Inc 60
Early research (Phase 1)Active Not RecruitingNCT05238922
What this trial is testing

Study of INCB123667 in Subjects With Advanced Solid Tumors

Who this might be right for
Solid Tumors
Incyte Corporation 291
Very early researchUnknownNCT05180851
What this trial is testing

Safety and Efficacy of Recombinant Oncolytic Adenovirus L-IFN Injection in Relapsed/Refractory Solid Tumors Clinical Study

Who this might be right for
Head and Neck CancerMelanomaBreast Cancer+4 more
Shanghai Fengxian District Central Hospital 28
Not applicableActive Not RecruitingNCT05359237
What this trial is testing

Vincristine Pharmacokinetics in Infants

Who this might be right for
Hematopoietic and Lymphoid Cell NeoplasmMalignant Solid Neoplasm
Children's Oncology Group 83
Early research (Phase 1)Study completedNCT01665183
What this trial is testing

Ph 1 Trial of ADI-PEG 20 Plus Cisplatin in Patients With Metastatic Melanoma

Who this might be right for
Cutaneous Melanoma, Uveal Melanoma, Ovarian Carcinoma or Other Advanced Solid Tumors
Polaris Group 8
Testing effectiveness (Phase 2)Looking for participantsNCT07022002
What this trial is testing

SSGJ-705 Monotherapy and Combination Therapy in Advanced HER2-Expressing Solid Tumors

Who this might be right for
Locally Advanced, Recurrent or Metastatic Malignancies
Shenyang Sunshine Pharmaceutical Co., LTD. 340
Early research (Phase 1)Active Not RecruitingNCT07038369
What this trial is testing

ATV-1601 in Patients With Advanced Cancer That Have AKT1 E17K Mutations

Who this might be right for
Advanced Solid TumorsBreast CancerBreast Carcinoma+24 more
Atavistik Bio, Inc 134
Early research (Phase 1)WithdrawnNCT00442741
What this trial is testing

Evaluate the Effects of Patupilone on the Pharmacokinetics of Midazolam and Omeprazole in Patients With Advanced Malignancies (Extension)

Who this might be right for
Solid Tumors
Novartis Pharmaceuticals
Early research (Phase 1)Study completedNCT02614456
What this trial is testing

Combination of Interferon-gamma and Nivolumab for Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Fox Chase Cancer Center 26
Next Page
694